Efficacy of Tranexamic Acid in Conservation of Blood Loss in Total Knee Arthroplasty Patients

被引:0
作者
Prabhu, T. [1 ]
Deepak, Manoj [1 ]
Harish, R. [1 ]
Narasimhan, Vijaya [1 ]
机构
[1] Bharath Univ, Sree Balaji Med Coll & Hosp, Dept Orthopaed, Madras 600044, Tamil Nadu, India
来源
RESEARCH JOURNAL OF PHARMACEUTICAL BIOLOGICAL AND CHEMICAL SCIENCES | 2015年 / 6卷 / 02期
关键词
Blood loss; Tranexamic acid; Total knee arthroplasty;
D O I
暂无
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
A lot of post-operative blood loss is usually associated with total knee arthroplasty. However, intra operative blood loss is minimal. Our study aims to evaluate the efficacy of tranexamic acid in reducing the blood loss. We conducted a randomised double blinded placebo study involving 36 patients (18 subjects and 18 control). Patients were administered either tranexamic acid or normal saline 30 minutes prior to the surgery and then 8th hourly for 3 days. Blood loss and blood units given before after the procedure was noted. Coagulation profile was noted. D Dimer values were also noted to evaluate fibrinolysis. The blood loss in patients who were administered Tranexamic acid was 635 ml and the placebo had 1325 ml with 24 hours after the surgical procedure. 11 patients in the control received 1 -4 units of packed cells and 3 patients in the other group. The packed cell volume in the patients who received tranexamic acid was higher though they received lesser blood transfusion. Plasminogen was decreased in the same group. All the other parameters such as bleeding time, Fibrinogen degradation product, platelet count, Prothrombin time, apTT were the same in both the groups. However d dimer concentrations were increased in the control group. There was no thrombo embolic complications in the tranexamic acid group compared to 3 patients in the control group.
引用
收藏
页码:987 / 992
页数:6
相关论文
共 32 条
[1]  
ASTEDT B, 1991, TRANEXAMIC ACID POTE
[2]  
BECKER J, 1968, ACTA CHIR SCAND, V134, P343
[3]   TREATMENT WITH THE FIBRINOLYTIC INHIBITOR TRANEXAMIC ACID - RISK FOR THROMBOSIS? [J].
Bekassy, Z. ;
Astedt, B. .
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA, 1990, 69 (04) :353-354
[4]   APPLICATION OF PHARMACOKINETIC DATA FROM HEALTHY-VOLUNTEERS FOR THE PREDICTION OF PLASMA-CONCENTRATIONS OF TRANEXAMIC ACID IN SURGICAL PATIENTS [J].
BENONI, G ;
BJORKMAN, S ;
FREDIN, H .
CLINICAL DRUG INVESTIGATION, 1995, 10 (05) :280-287
[5]  
Benoni G, 1995, Am J Knee Surg, V8, P88
[6]  
BENONI G, 1994, ACTA ORTHOP SCA S256, V65, P101
[7]   DEMONSTRATION OF A FIBRINOLYTIC ACTIVATOR IN RED BONE MARROW [J].
BJOERKMAN, S ;
NILSSON, IM .
ACTA HAEMATOLOGICA, 1961, 26 (05) :273-&
[8]   EFFECT OF DEXTRAN ON FIBRINOLYSIS INHIBITION-ACTIVITY IN THE BLOOD AFTER MAJOR SURGERY [J].
CARLIN, G ;
KARLSTROM, G ;
MODIG, J ;
SALDEEN, T .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1980, 24 (05) :375-378
[9]  
COLLINS DN, 1991, CLIN ORTHOP RELAT R, P128
[10]  
CUSHNER FD, 1991, CLIN ORTHOP RELAT R, P98